Tuesday, August 4, 2026

Chung Dong-young: “Sanctions and Human Rights Pressure Do Not Enhance Negotiation Leverage with North Korea”… Again Out of Sync with US

South Korea's Unification Minister challenges U.S. sanctions on North Korea, advocating for dialogue and peace measures over isolation.

Korean Startup Presents REBEL-Quad Architecture at Semiconductor Conference

Rebellions unveiled its REBEL-Quad AI chip at ISSCC 2026, showcasing advanced architecture and superior performance for AI workloads.

How Google’s AI Investment Boosts Demand for HBM and D-RAM: Insights for 2026

Big Tech's AI investments boost demand for semiconductors, benefiting Samsung and SK Hynix while promising growth in non-memory sectors.

Tag: Nesuparib

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Nesuparib: The Revolutionary Dual-Inhibitor for Pancreatic Cancer – Can It Outperform Existing Treatments?

Nesuparib shows promise in inhibiting pancreatic cancer metastasis, offering hope for patients regardless of BRCA mutation status.

Nesuparib: The Game-Changing Cancer Treatment for Small Cell Lung Cancer Revealed at AACR 2026

Onconic Therapeutics reveals Nesuparib's promising preclinical results for small cell lung cancer, outperforming existing treatments significantly.

Next-Gen Cancer Drug Nesuparib: How It Outperforms Olaparib in SCLC and Pancreatic Cancer

Onconic Therapeutics will present Nesuparib research at AACR 2026, showcasing its potential for various cancers and overcoming PARP inhibitor limitations.

Nesuparib: A Game-Changer in Cancer Treatment? Key Findings from AACR 2026

Onconic Therapeutics' Nesuparib shows promising results against small cell lung and pancreatic cancers, highlighting its competitive edge.

Nesuparib vs. Traditional Treatments: Will This New Dual-Target Cancer Drug Change the Game for Ovarian Cancer?

Onconic Therapeutics advances Nesuparib into Phase 2 trials for ovarian cancer, aiming to validate a novel re-maintenance therapy approach.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.